Segluromet

Segluromet combines Metformin Hydrochloride and Ertugliflozin for oral use, aiding in blood sugar management. This medication is designed to support individuals with type 2 diabetes in maintaining healthy glucose levels.

Segluromet is primarily used for managing type 2 diabetes by improving blood sugar control. It works by enhancing the body's response to insulin and reducing glucose absorption in the kidneys. This combination therapy is often prescribed when diet and exercise alone are not sufficient to manage blood sugar levels effectively.

Common effects of Segluromet may include symptoms such as nausea, diarrhea, and headache. Some individuals might experience urinary tract infections or low blood sugar levels. These effects can vary in intensity and duration, depending on the individual's response to the medication.

Segluromet should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is important to stay hydrated and monitor blood sugar levels regularly. Consult a healthcare provider before starting or adjusting the dosage of this medication.

Segluromet may interact with certain medications, including insulin, diuretics, and other diabetes drugs. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.